Nicotine metabolism and CYP2A6 allele frequencies in Koreans

被引:80
作者
Kwon, JT
Nakajima, M
Chai, S
Yom, YK
Kim, HK
Yamazaki, H
Sohn, DR
Yamamoto, T
Kuroiwa, Y
Yokoi, T
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Div Drug Metab, Kanazawa, Ishikawa 9200934, Japan
[2] Soonchunhyang Univ, Dept Clin Pharmacol, Coll Med, Chonan, South Korea
[3] Showa Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Tokyo 142, Japan
来源
PHARMACOGENETICS | 2001年 / 11卷 / 04期
关键词
genetic polymorphism; nicotine gum; cotinine formation; interindividual variation;
D O I
10.1097/00008571-200106000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CYP2A6 is a major catalyst of nicotine metabolism to cotinine, Previously, we demonstrated that the interindividual difference in nicotine metabolism is related to a genetic polymorphism of the CYP2A6 gene in Japanese. To clarify the ethnic differences in nicotine metabolism and frequencies of CYP2A6 alleles, we studied nicotine metabolism and the CYP2A6 genotype in 209 Koreans. The cotinine/nicotine ratio of the plasma concentration 2 h after chewing one piece of nicotine gum was calculated as an index of nicotine metabolism. The genotypes of CYP2A6 gene (CYP2A6*1A, CYP2A6*1B, CYP2A6*2, CYS2A6*3, CYP2A6*4 and CYP2A6*5) were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism or allele specific(AS)-PCR. There were ethnic differences in the allele frequencies of CYP2A6*1A, CYP2A6*2B, CYP2A6*4 and CYP2A6*5 between Koreans (45.7%, 42.8%, 11.0% and 0.5%, respectively) and Japanese (42.4%, 37.5%, 20.1% and 0%, respectively, our previous data). Similar to the Japanese, no CYP2A6*2 and CYP2A6*3 alleles were found in Koreans, The homozygotes of the CYP2A6*4 allele (four subjects) were completely deficient in cotinine formation, being consistent with the data among Japanese. The heterozygotes of CYP2A6*4 tended to possess a lower metabolic ratio (CYP2A6*1A/CYP2A6*4, 4.79 +/-3.17; CYP2A6*1B/CYP2A6*4, 7.43 +/- 4.97) than that in subjects without the allele (CYP2A6*1A/CYP2A6*1A, 7.42 +/- 6.56; CYP2A6*1A/CYP2A6*1B, 9.85 +/- 16.12; CYP2A6*1B/CYP2A6*1B, 11.33 +/- 9.33). The subjects who possess the CYP2A6*1B allele appeared to show higher capabilities of cotinine formation. It was confirmed that the interindividual difference in nicotine metabolism was closely related to the genetic polymorphism of CYP2A6, The probit plot of the metabolic ratios in Koreans (8.73 +/- 11.88) was shifted to a higher ratio than that in the Japanese (3.78 +/- 3.09), In each genotype group, the Korean subjects revealed significantly higher metabolic ratios than the Japanese subjects, The ethnic difference in cotinine formation might be due to environmental and/or diet factors as well as genetic factors. Pharmacogenetics 11:317-323 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 26 条
[1]   DEFICIENT C-OXIDATION OF NICOTINE [J].
BENOWITZ, NL ;
JACOB, P ;
SACHS, DPL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) :590-594
[2]   Genetic polymorphism of CYP2A6 in the German population [J].
Bourian, M ;
Gullstén, H ;
Legrum, W .
TOXICOLOGY, 2000, 144 (1-3) :129-137
[3]   Racial and ethnic differences in serum cotinine levels of cigarette smokers - Third National Health and Nutrition Examination Survey, 1988-1991 [J].
Caraballo, RS ;
Giovino, GA ;
Pechacek, TF ;
Mowery, PD ;
Richter, PA ;
Strauss, WJ ;
Sharp, DJ ;
Eriksen, MP ;
Pirkle, JL ;
Maurer, KR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02) :135-139
[4]   Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method [J].
Chen, GF ;
Tang, YM ;
Green, B ;
Lin, DX ;
Guengerich, FP ;
Daly, AK ;
Caporaso, NE ;
Kadlubar, FF .
PHARMACOGENETICS, 1999, 9 (03) :327-332
[5]   POOR METABOLIZERS OF NICOTINE AND CYP2D6 POLYMORPHISM [J].
CHOLERTON, S ;
ARPANAHI, A ;
MCCRACKEN, N ;
BOUSTEAD, C ;
TABER, H ;
JOHNSTONE, E ;
LEATHART, J ;
DALY, AK ;
IDLE, JR .
LANCET, 1994, 343 (8888) :62-63
[6]   EXPRESSION AND ALTERNATIVE SPLICING OF THE CYTOCHROME-P-450 CYP2A7 [J].
DING, SH ;
LAKE, BG ;
FRIEDBERG, T ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1995, 306 :161-166
[7]   THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS [J].
FERNANDEZSALGUERO, P ;
GONZALEZ, FJ .
PHARMACOGENETICS, 1995, 5 :S123-S128
[8]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
[9]  
Finney D.J., 1964, Probit Analysis
[10]   CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians [J].
Inoue, K ;
Yamazaki, H ;
Shimada, T .
ARCHIVES OF TOXICOLOGY, 2000, 73 (10-11) :532-539